The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.50BHKD
700.49M · vs all stocks (USD)
Updated Nov 20, 2026
Revenue (TTM)
7.05BCNY
899.02M · vs all stocks (USD)
Updated Nov 20, 2026
Profit Margin
-34.47%
Updated Nov 20, 2026
Beta
0.5990x
vs all stocks
Updated Nov 20, 2026
52-Week Change
-34.52%
vs all stocks
Updated Nov 20, 2026
Market Capitalization
5.50BHKD
700.49M · vs all stocks (USD)
Updated Nov 20, 2026
Enterprise Value
27.18BHKD
3.46B · vs all stocks (USD)
Updated Nov 20, 2026
Forward P/E
1.43x
Updated Nov 20, 2026
Price to Sales (TTM)
0.3286x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.78×.Updated Nov 20, 2026
Price to Book (MRQ)
0.3075x
Updated Nov 20, 2026
Enterprise to Revenue
3.85x
Updated Nov 20, 2026
Enterprise to EBITDA
-16.19x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 59.33×.Updated Nov 20, 2026
Gross Margin
19.17%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -0.69%.Updated Nov 20, 2026
Profit Margin
-34.47%
Updated Nov 20, 2026
Operating Margin
-31.01%
Updated Nov 20, 2026
Return on Assets (TTM)
-2.72%
Updated Nov 20, 2026
Return on Equity (TTM)
-24.54%
Updated Nov 20, 2026
Revenue (TTM)
7.05BCNY
899.02M · vs all stocks (USD)
Updated Nov 20, 2026
Revenue per Share (TTM)
1.76CNYUpdated Nov 20, 2026
Quarterly Revenue Growth
-6.80%
Updated Nov 20, 2026
Gross Profit (TTM)
-48.99MCNY
-6.24M · vs all stocks (USD)
Updated Nov 20, 2026
EBITDA (TTM)
458.15MCNY
58.40M · vs all stocks (USD)
Updated Nov 20, 2026
Net Income (TTM)
-2.43BCNY
-309.85M · vs all stocks (USD)
Updated Nov 20, 2026
Quarterly Earnings Growth (YoY)
-3.32%
Updated Nov 20, 2026
Operating Cash Flow (TTM)
1.90BCNY
242.30M · vs all stocks (USD)
Updated Nov 20, 2026
Levered Free Cash Flow (TTM)
647.52MCNY
82.53M · vs all stocks (USD)
Updated Nov 20, 2026
5-Year Average Dividend Yield
2.40%
vs all stocks
Updated Nov 20, 2026
Payout Ratio
0.00%
Updated Nov 20, 2026
Minority Interest (Equity)
2.46BCNYFY2025 · Dec 31, 2025
Revenue
6.06BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
4.08BCNYFY2025 · Dec 31, 2025
Gross Profit
1.98BCNYFY2025 · Dec 31, 2025
Operating Income
207.41MCNY
31.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-2.92BCNYFY2025 · Dec 31, 2025
Income Tax Expense
304.00MCNYFY2025 · Dec 31, 2025
Net Income
-3.22BCNYFY2025 · Dec 31, 2025
EBIT
-2.00BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
458.15MCNYFY2025 · Dec 31, 2025
Research & Development
13.45MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
408.58MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
549.20MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
26.22MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
921.01MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.8900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.8900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
3.36BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
3.36BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-3.22BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
236.57MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-7.33MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-69.55MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
6.38BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-3.22BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
930.12MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
386.14MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
1.90BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-62.21MCNYFY2025 · Dec 31, 2025
Net Acquisitions
4.78MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-4.66MCNYFY2025 · Dec 31, 2025
Sale of Investments
3.30MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-70.43MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-129.21MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
2.47BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-3.07BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-980.96MCNYFY2025 · Dec 31, 2025
Other Financing Charges
176.49MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.40BCNYFY2025 · Dec 31, 2025
Shares Outstanding
3.37BSharesUpdated Nov 20, 2026
Float Shares
1.98BSharesUpdated Nov 20, 2026
% Held by Insiders
0.00%
vs all stocks
Updated Nov 20, 2026
% Held by Institutions
1.13%
vs all stocks
Updated Nov 20, 2026
Total Cash (MRQ)
8.32BCNY
1.06B · vs all stocks (USD)
Updated Nov 20, 2026
Total Cash per Share (MRQ)
2.10CNYUpdated Nov 20, 2026
Total Debt (MRQ)
30.33BCNY
3.87B · vs all stocks (USD)
Updated Nov 20, 2026
Total Debt to Equity (MRQ)
3.28x
Updated Nov 20, 2026
Current Ratio (MRQ)
2.06x
Updated Nov 20, 2026
Book Value per Share (MRQ)
1.90CNYUpdated Nov 20, 2026
Total Assets
43.17BCNY
6.47B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
31.87BCNYFY2025 · Dec 31, 2025
Total Liabilities
34.01BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
11.30BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
17.10BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
16.91BCNYFY2025 · Dec 31, 2025
Cash
7.06BCNYFY2025 · Dec 31, 2025
Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
7.06BCNYFY2025 · Dec 31, 2025
Accounts Receivable
208.84MCNYFY2025 · Dec 31, 2025
Inventory
22.24BCNYFY2025 · Dec 31, 2025
Accounts Payable
3.92BCNYFY2025 · Dec 31, 2025
Short-term Debt
9.29BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
187.16MCNYFY2025 · Dec 31, 2025
Long-term Debt
15.64BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
3.37BCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.36BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
9.16BCNY
1.37B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
0.5450HKDUpdated Nov 20, 2026
52-Week High
1.01HKDUpdated Nov 20, 2026
52-Week Change
-34.52%
vs all stocks
Updated Nov 20, 2026
Beta
0.5990x
vs all stocks
Updated Nov 20, 2026
50-Day MA
0.6539HKDUpdated Nov 20, 2026
200-Day MA
0.7306HKDUpdated Nov 20, 2026
Avg 10-Day Volume
1.44MSharesUpdated Nov 20, 2026
Avg 30-Day Volume
1.99MSharesUpdated Nov 20, 2026
Diluted EPS (TTM)
-0.6900CNYUpdated Nov 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The balance sheet has shrunk four years running, and inventory is much of what remains.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Looks liquid, but the distress score says otherwiseNotable